Dextromethorphan transdermal delivery device

Provided herein are transdermal delivery devices comprising dextromethorphan. The transdermal delivery device can be characterized by the novel design, for example, with an adhesive layer and a reservoir layer, with an adhesive layer comprising a mixture of two adhesives, and/or with a skin permeati...

Full description

Saved in:
Bibliographic Details
Main Author BORSADIA SURESH
Format Patent
LanguageChinese
English
Published 26.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are transdermal delivery devices comprising dextromethorphan. The transdermal delivery device can be characterized by the novel design, for example, with an adhesive layer and a reservoir layer, with an adhesive layer comprising a mixture of two adhesives, and/or with a skin permeation enhancer, e.g., in an amount that can significantly enhance the flux of dextromethorphan. The transdermal delivery device can also be characterized by its in vitro and/or in vivo release profile, for example, that can provide a desired pharmacokinetic profile described herein. Also provided herein are methods of administering dextromethorphan, and methods of treating a disease or disorder described herein, using the transdermal delivery device herein. 本文提供了包含右美沙芬的经皮递送装置。所述经皮递送装置的特征可在于新型设计,例如具有粘合剂层和贮藏层、具有包含两种粘合剂的混合物的粘合剂层和/或具有例如其量可以显著增强右美沙芬的通量的皮肤渗透增强剂。所述经皮递送装置的特征还可在于其体外和/或体内释放曲线,例如,其可以提供本文所述的所需的药代动力学曲线。本文还提供了使用本文的所述经皮递送装置施用右美沙芬的方法以及治疗本文所述疾病或病症的方法。
Bibliography:Application Number: CN201880072989